approval
savePAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approval
community read0 votes
Sponsor: PFIZER. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 6
- approvalPAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approvalFeb 11, 2026 · 241d ago
- approvalPAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approvalFeb 11, 2026 · 241d ago
- approvalPAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approvalFeb 12, 2025 · 605d ago
- approvalPAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approvalJan 31, 2025 · 617d ago
- approvalPAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approvalNov 19, 2024 · 690d ago
- approvalPAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approvalMay 25, 2023 · 1234d ago
same company · ±60 days · 6
- approvalelranatamab: ELREXFIO (ELRANATAMAB) — FDA approvalSep 10, 2024
- approvaltofacitinib citrate ER: XELJANZ XR (TOFACITINIB CITRATE) — FDA approvalSep 27, 2024
- approvaltofacitinib citrate ER: XELJANZ (TOFACITINIB CITRATE) — FDA approvalSep 27, 2024
- approvalMETHYLPREDNISOLONE — FDA approvalOct 11, 2024
- approvalmarstacimab: HYMPAVZI (MARSTACIMAB-HNCQ) — FDA approvalOct 11, 2024
- approvalMETHYLPREDNISOLONE — FDA approvalOct 11, 2024
comments(0)
5-min edit window · permanent after that